Sylvia S. W. Ng

Effects of the epidermal growth factor receptor inhibitor OSI-774, Tarceva, on downstream signaling pathways and apoptosis in human pancreatic adenocarcinoma.

Sylvia S. W. Ng, Ming‐Sound Tsao, Trudey Nicklee et al. · PubMed · 2002 · 165 citations

Downstream Signaling Pathways, Cell Death, Pathology +17

Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) overexpression in pancreatic ductal adenocarcinoma correlates with poor survival

David F. Schaeffer, Daniel R Owen, Howard J. Lim et al. · BMC Cancer · 2010 · 124 citations · Full text

Phase 1 Trial of Sorafenib and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma

Anthony Brade, Sylvia S. W. Ng, James D. Brierley et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 112 citations

Radiation Medicine, Hepatology, Radiation Therapy +9

The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model

Elizabeth Donohue, Anitha Thomas, Norbert Maurer et al. · Journal of Cancer · 2013 · 106 citations · Full text

Mitophagy, Antitumor Activity, Pathology +17

Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogues.

Sylvia S. W. Ng, Michael Gütschow, Sunna Hauschildt et al. · PubMed · 2003 · 85 citations

Medicinal Chemistry, Angiogenesis, Chemoprevention Strategy +15